03/16/2010
OSI Pharmaceuticals Comments on Astellas' Slate of Director Nominees
03/15/2010
OSI Pharmaceuticals' Board of Directors Unanimously Rejects Astellas' Unsolicited Tender Offer
If you are a member of the media, please call our Corporate Relations department:
| Kathy Galante Senior Director, Investor and Public Relations Phone: 631-962-2043 Email: kgalante@osip.com |
Kim Wittig Director, Public Relations Phone: 631-962-2135 Email: kwittig@osip.com |